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ABSTRACT  
FACTORS ASSOCIATED WITH SUCCESSFUL TISSUE HARVEST FOR DESCEMET’S 
MEMBRANE ENDOTHELIAL KERATOPLASTY 
David C. Shield and Jimmy K. Lee.  Department of Ophthalmology and Visual Science, Yale University 
School of Medicine, New Haven, Connecticut. 
Several challenges prohibit Descemet’s Membrane Endothelial Keratoplasty (DMEK) from becoming 
widely adopted as the next generation of corneal transplant for corneal endothelial dysfunction.  To date, 
there have been no evaluations of donor cornea attributes associated with tissue harvest for DMEK.  The 
aim of this study was to describe a method for harvesting the Descemet’s membrane and endothelial graft 
and to evaluate a series of dissections of human corneas for factors associated with successful harvest. 
Forty human donor corneas were obtained from tissue and eye banks.  Endothelial surfaces were stained 
with trypan blue dye and then scored with 8.5 mm disposable trephines. Harvesting of Descemet’s 
membrane-endothelial graft was attempted using smooth forceps and hydrodissection with application of 
balanced salt solution (BSS) to the interface between tissue graft and adherent stroma.  Donor cornea 
variables (sex, age, time from death to preservation, time from death to dissection) and factors such as 
warming donor tissue to room temperature were recorded for each harvest attempt. 
Twenty-eight of forty (70%) Descemet’s membranes were peeled successfully with this technique. After 
adjusting for donor cornea age, sex, and time from death to preservation, soaking the donor tissue for 60 
minutes in ambient temperature BSS was found to be the only factor significantly associated with 
successful membrane harvest (p=0.044).  Twenty-six of 32 corneas (81.3%) that had been warmed were 
successfully peeled, whereas on 2 of 8 (25.0%) of unwarmed corneal peels were successful. These results 
highlight the importance of warming and rehydrating the donor cornea for an hour or more in BSS prior to 
dissection.  However, additional challenges trouble the remaining steps of Descemet’s membrane 
endothelial keratoplasty; future directions for the field are presented, including possibilities for refinement 
of the DMEK technique and hybrid DSAEK/DMEK techniques.  We have developed one such hybrid 
technique using thin-cut grafts (40-70 microns) to combine the advantages of DMEK (topical anesthesia, 
clear corneal incision, less induced hyperopia) with the ease of graft manipulation allowed by thicker 
endothelial grafts used in traditional DSAEK. 
 
 Shield 2 
ACKNOWLEDGEMENTS  
 
I would like to thank Dr. Jimmy Lee for his tireless support and enthusiasm.  He has been 
a superb mentor and role model.  His knowledge and insight have been inspirational to 
me and have played no small role in my decision to pursue ophthalmology as a career. 
 
I would also like to thank my other mentors within the Yale Eye Center, especially Dr. 
Ron Adelman, whose teaching and support guided me through my clinical experience, 
academic research, and the residency application process.   
 
I would be remiss to exclude the fabulous staff at the Yale Eye Center and the ambulatory 
surgical center; thank you all for putting up with my on-going presence and supporting 
me in my training.  In addition, I deeply appreciate the support of Yale University School 
of Medicine Office of Student Research, which funded three months of full-time research 
on this project. 
 
Lastly, I owe a deep debt of gratitude to my various readers and editors, including to Dr. 
Aryan Shayegani, to my fiancée Nedra Rauschenberg (who helped me to keep the 
medical jargon to a minimum and whose loving support keeps me going), and to my 
parents, Renée and Paul Shield, without whom none of this would have been possible.  
Their collective assistance has vastly improved this research and writing; all mistakes and 
errors are, however, my own. 
 
 Shield 3 




a. Overview of corneal function, anatomy, and histology...............................4 
b. Indications for corneal transplantation.........................................................7 
c. History of corneal transplantation..............................................................14 
d. Current state of endothelial keratoplasty ...................................................19 
II. Statement of Purpose and Hypothesis .........................................................23 
III. Methods...........................................................................................................25 
a. Donor tissue acquisition.............................................................................25 
b. Membrane harvesting procedure................................................................25 
c. Data collection ...........................................................................................28 
d. Statistical analysis......................................................................................28 
e. Statement of student contribution ..............................................................29 
IV. Results .............................................................................................................31 
a. Characteristics of donor tissue ...................................................................31 
b. Results of harvesting procedure.................................................................31 
c. Logistic regression analysis .......................................................................32 
V. Discussion .......................................................................................................33 
a. Summary and implications ........................................................................33 
b. Limitations of the study .............................................................................35 
c. Future directions: Hybrid DSEK/DMEK techniques and InjEK...............36 
VI. References.......................................................................................................39 
VII. Figures.............................................................................................................44 
VIII. Tables ..............................................................................................................48 
 













Overview of corneal function, anatomy, and histology 
 
The cornea is the anterior transparent wall of the globe of the eye.  A well-
functioning cornea is crucial to the function of the eye and to enabling vision.  The 
cornea, along with the tear film, is the major refractive component of the eye, providing 
approximately two-thirds of the optical power of the eye (about 43 diopters), with the rest 
of the optical power provided by the aqueous humor, vitreous humor, and the lens.  The 
cornea also provides structural integrity to the anterior portion of the eye and protects the 
eye from infection.  Its transparency and near total lack of vascularity are critical to 
transmitting light to the posterior components of the visual system.  When the cornea is 
damaged or becomes diseased, its normal function is disrupted and it can become 
translucent or opaque, resulting in varying levels of decreased vision.  Corneal 
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transplantation seeks to replace the diseased cornea with a healthy cadaveric cornea.   
The cornea is made up of discrete layers or lamellae (Figure 1).  The outermost 
layer is a non-keratinized stratified squamous epithelium approximately 5-6 cell layers in 
thickness.  The epithelial layer serves to protect the eye and provides refractive surface 
that is kept smooth by the overlying tear film.  It is this interface between air and tear 
film and cornea that provides the bulk of the eye’s refractive power.  The exposed layer 
of epithelium is continuously shed and replaced by division of the basal layer of 
columnar epithelium, with the entire epithelium replacing itself every 7-10 days.  
Epithelial stem cells are present in the basal layer of the limbus, at the circumference of 
the cornea.  The stem cells undergo differentiation into basal cells and epithelial cells as 
they migrate towards the center of the cornea; their complex role is responsible for the 
maintenance of a constant epithelial cell density (1). 
Under the basement membrane of the epithelial cell layer lies Bowman’s layer of 
acellular condensed collagen fibers, which measures approximately 14 microns in 
thickness.  Beyond being a structural component of the cornea, it is richly innervated by 
the terminal branches of the nasociliary nerve, providing sensation to the cornea (2).  
Beneath Bowman’s layer begins the thickest layer of the cornea, the transparent stroma 
(histologically the lamina propria), which takes up over three-quarters of the thickness of 
the cornea.  The stroma consists of approximately 200 layers of type I collagen fibers 
organized in parallel along with a sparsely distributed network of keratocyte.  The stroma 
provides important structural integrity to the globe of the eye and the precise organization 
of the collagen fibers is important for transmitting light with minimal scattering.  It is 
theorized that transparency of the stroma is maintained by the tight and regular 
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arrangement of these collagen fibers, with one layer of parallel fibers at an angular offset 
from the layers above and below it (3).  The major cell type of the stroma is the 
keratocyte, which are interspersed within the stroma and normally quiescent.  However, 
they become activated when repair or maintenance is needed, as in the case of a corneal 
wound or trauma, enlarging and transforming into fibroblasts to assist in repair of the 
injury.  They are further responsible for maintenance of the stromal extracellular matrix 
(4).   
Descemet’s membrane (also called the posterior limiting membrane) is the 
basement membrane that underlies the stroma; it extends to the periphery of the anterior 
globe wall to fuse with the trabecular meshwork at Schwalbe’s line.  It is secreted by the 
endothelial cell layer that lies just below it, and thickens over a lifetime from 
approximately 3 microns at birth to 10 microns in adulthood.   
The corneal endothelium is a monolayer of simple squamous cells that take on a 
hexagonal honeycomb appearance due to their tight arrangement.  The endothelium is 
bathed in the aqueous humor of the anterior chamber of the eye and its cells are 
responsible for regulating fluid and solute transport between the aqueous humor and the 
rest of the corneal tissue.  Through multiple mechanisms it produces a net flow of fluid 
from the cornea into the aqueous humor and maintains the normal cornea at 78% water 
content (5).  This relatively dry state of the cornea is instrumental to maintaining corneal 
transparency. 
Unlike the corneal epithelium, endothelial cells do not regenerate and their 
numbers decline throughout the lifespan, beginning at about 3000-4000 cells/mm2 in 
childhood and declining to approximately 2600 cells/mm2 in the elderly at a rate of cell 
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loss of 0.6% per year(6).  Endothelial cells may be lost as part of the normal aging 
process, or through a variety of other mechanisms, including trauma (both direct trauma 
to the endothelium and the downstream effects of indirect trauma to the anterior cornea), 
surgical manipulation, intracameral pharmacological agents, increased intraocular 
pressure, and several endothelium-specific disease processes (7).  When cells are lost, the 
remaining endothelial cells stretch and become larger in size (polymegathism) to 
compensate for the reduced cell density.  The regular hexagonal honeycomb pattern of 
the endothelial cells becomes less regular as cells take on a variety of sizes and shapes 
(pleomorphism).  Research suggests that both polymegathism and pleomorphism are 
signs of impaired endothelial function (8). 
The impairment of endothelial function may begin gradually as endothelial cells 
are lost, but as the cell density drops lower (below 1000 cells/mm2 and especially below 
500 cells/mm2), the endothelium can no longer adequately extract fluid from the cornea, 
resulting in corneal edema and loss of transparency.  Endothelial dysfunction from any 
etiology is thus an important cause of decreased vision and blindness and one of the 
major indications for corneal transplantation. 
 
Indications for corneal transplantation 
 
Corneal transplantation (keratoplasty) aims to replace the injured or diseased 
portions of the cornea with tissue from a deceased donor cornea when other medical and 
surgical modalities of treatment have failed.  There are several major indications for 
keratoplasty including Fuchs’ endothelial dystrophy, pseudophakic and aphakic bullous 
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keratopathies, keratoconus, keratitis of various kinds, trauma, stromal dystrophies, and to 
correct a previous failed graft.  In a retrospective chart review of over 1,500 corneal 
transplants at the Wills Eye Hospital from 1996 to 2000, Cosar et al. found the leading 
indications to be pseudophakic bullous keratopathy (27.2%), regraft (18.1%), 
keratoconus (15.4%), and Fuchs’ endothelial dystrophy (15.2%) (9).  The following 
review of these diseases and their respective indications for keratoplasty, while not 
intended to be exhaustive, serves as a foundation for understanding the research into 
endothelial keratoplasty that was performed in the present study. 
 
Fuchs’ Endothelial Dystrophy 
 Fuchs’ endothelial dystrophy is a bilateral degenerative disorder of the corneal 
endothelium characterized by thickening of Descemet’s membrane, the accumulation of 
discrete excrescences (called guttae or corneal guttata) in the central area of the cornea, 
folds of Descemet’s membrane, loss and decreased function of endothelial cells, and 
resulting decreased vision from corneal edema (See Figure 2).  Fuchs’ is more common 
among women and has been linked to an autosomal dominant inheritance pattern (10,11). 
 As the corneal endothelium degenerates, there is a decrease in the concentration 
of endothelial cells and increased polymegathism and pleomorphism, resulting in corneal 
edema, as previously mentioned.  Edema of the stroma first occurs upon wakening with 
resolution throughout the day; patients report blurred vision primarily in the morning.  
Later in the disease process, the edema does not resolve over the course of the day and 
patients have no daily improvement in vision. As the disease progresses to its end-stage, 
the endothelium becomes progressively more dysfunctional and edema affects both the 
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stroma and eventually the epithelium as well.  Epithelial involvement can severely limit 
vision, both through loss of the smooth interface with the tear film and the air and from 
the increased risk of corneal erosions.  Stromal edema can cause blisters and bullae to 
form on the epithelial surface, with resulting pain, photophobia, epiphoria, and sloughing 
of the epithelium as bullae rupture.  Treatment is limited to surgical options at this late 
stage of Fuchs’, which traditionally have focused on full-thickness penetrating 
keratoplasty.  However, in recent years endothelial keratoplasties such as DLEK (Deep 
Lamellar Endothelial Keratoplasty), DSEK (Descemet’s Stripping Endothelial 
Keratoplasty), and DMEK (Descemet’s Membrane Endothelial Keratoplasty) have 
started to supplant penetrating keratoplasty for this disease entity, with post-surgical 
visual acuity of 20/40 or better in about 60 to 70 percent of patients (12-15).   
 
Pseudophakic and Aphakic Bullous Keratopathies 
 Pseudophakic and aphakic bullous keratopathy are also diseases of endothelial 
dysfunction that occur as a result of cataract extraction with or without intraocular lens 
placement.  Routine cataract extraction can reduce the endothelial cell count by around 
10 percent, which may result in endothelial dysfunction in a patient with low cell density 
or other predispositions (e.g., mild unrecognized endothelial dystrophy). 
 Damage to the endothelium can occur during cataract surgery through several 
mechanisms.  Direct mechanical trauma to the endothelium can result from surgical 
instrumentation or from the clear corneal incision.  Intraocular lenses (especially those 
made of polymethylmethacrylate) can severely damage the endothelial surface if contact 
occurs between the two surfaces on insertion of the lens.  Iris-fixated lenses and anterior 
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chamber lenses with a closed loop design have been shown to come into intermittent 
contact with the endothelium, thus contributing to endothelial cell loss. Further, the 
preservatives in some intraocular medications, such as some preparations of lidocaine, as 
well as high doses of intracamaral vancomycin have been shown to result in endothelial 
cell loss. 
Surgical techniques, such as the use of viscoelastics (which can protect the 
endothelium to varying degrees, depending on the type of viscoelastic used), use of 
preservative-free intracameral anesthesia, and deepening of the anterior chamber prior to 
IOL insertion, are used to reduce the risk of contact between the intraocular lens and the 
endothelial surface (16). 
Patients with pseudophakic and aphakic bullous keratopathy may be candidates 
for either penetrating keratoplasty or endothelial keratoplasty, depending on the severity 
of the disease.  At the time of surgery, the intraocular lens may be exchanged. 
 
Keratoconus 
 Keratoconus is a sporadically occurring disease that affects the structure and 
curvature of the cornea, resulting in progressive corneal steepening, corneal thinning, 
induced myopia, and astigmatism.  Although the cause of keratoconus is unknown and in 
fact it may be caused by a variety of underlying etiologies, evidence suggests that the 
disorder is generally associated with increased activity of epithelial proteolytic enzymes 
and matrix metalloproteases, which degrade the integrity of the stroma (17).  Stromal 
degradation results in irregular steepening of the cornea, which is more pronounced 
inferiorly, and thinning of the central cornea.  The distorted curvature of the cornea can 
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be observed clinically, just as the ocular pulse can be appreciated as it is transmitted 
through the thinned corneal tissue.  As the cornea bulges out, stress lines can be seen in 
the stroma on examination and breaks can occur in Bowman’s layer.  Likewise, 
Descemet’s membrane can rupture acutely causing rapid increase in corneal edema and 
loss of vision (18). 
 Treatment for keratoconus begins with corrective lenses for myopia and 
astigmatism, followed by rigid contact lenses.  Surgical treatment is indicated once 
contact lenses fail to provide adequate visual acuity. Penetrating keratoplasty is the 
preferred surgical treatment for this disease, although deep anterior lamellar keratoplasty 
(DALK) is also possible and may have some advantages such as reduced graft rejection 
despite being a technically more challenging procedure (19).  Keratoconus rarely recurs 
after keratoplasty.   
Other surgeries, such as placement of intracorneal ring segments, may reduce 
myopia and astigmatism and improve visual acuity.  There is also promising research into 
less-invasive combined treatment with riboflavin and ultraviolet-A (UVA) radiation.  
This treatment induces collagen cross-linking in the stroma and thus increases the 
structural integrity of the cornea, limiting progression of the disease (20). 
 
Keratitis 
Keratitis may be infectious or non-infectious.  Infectious keratitis may be caused 
by bacteria, fungi, parasites, or viruses and is one of the leading causes of blindness in the 
world (21).  Once the diagnosis has been made via laboratory analysis of scrapings of a 
corneal ulcer and appropriate antibiotic therapy has been initiated, the extent of necrotic 
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cornea must be determined.  If the infection is limited to the anterior portion of the 
cornea, the surgeon may choose to perform only an anterior lamellar keratoplasty (22).  
However, if the depth of the infection is unclear or deeper than an anterior resection can 
successfully remove, a penetrating keratoplasty should be performed to ensure complete 
removal of the necrotic and infected tissue.  If the infection has resulted in perforation of 
the cornea, then penetrating keratoplasty may be used to replace the perforated cornea.  In 
cases of small perforations, cyanoacrylate glue may be applied to seal the perforation, at 
the surgeon’s discretion, instead of keratoplasty.  Likewise, in the case of a large, non-
perforating ulcer, a surgeon may choose to perform a penetrating keratoplasty (23). 
In the case of fungal keratitis, which can be particularly insensitive to antifungal 
therapies, surgical intervention may be considered early-on in instances of presumed 
therapeutic failure (24).  In viral keratitis due to herpes simplex (HSV), penetrating 
keratoplasty is performed for scarring due to recurrent infections or when the infection is 
leading to perforation, but rates of graft survival are low (25, 26).  Lamellar keratoplasty 
is typically not effective in these cases.  Penetrating keratoplasty may also be used in 
cases of peripheral ulcerative keratitis (PUK), but results are generally poor (27).  A 
variety of systemic diseases have ocular manifestations that include corneal inflammation 
to the extent that they may require penetrating keratoplasty (28). 
 
Trauma and Burns 
 Trauma to the eye can result in corneal perforation or scarring, both of which may 
be indications for penetrating keratoplasty.  Exposure to the cornea of either alkali or acid 
chemicals can have a large range of effects on the cornea, from mild irritation to severe 
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damage and vision loss, although alkali burns tend to be more severe than those caused 
by acidic agents.  After a chemical exposure is acutely managed, the extent of damage to 
the ocular surface must be assessed.  The chemical exposure may damage only the 
epithelium or it may progress deeper into the eye, damaging the stroma (destroying 
stromal keratocytes and limiting the capacity of the cornea to heal itself), endothelium, or 
deeper structures of the eye. Lamellar keratoplasty generally does not have a role in 
chemical burns.  In mild cases of chemical burn, penetrating keratoplasty may be 
performed to good effect, but the results of keratoplasty worsen with more extensive 
damage.  For example, burns to the conjunctiva and the limbus can destroy the limbal 
stem cells.  If enough stem cells are destroyed, the epithelium will not be able to 
replenish itself and a penetrating keratoplasty will fail.  Therefore, limbal stem cell 
transplantation must be performed prior to replacing the damaged cornea, in order to 
provide a new source of epithelial cells.  Other complications of chemical burns, such as 




 Corneal dystrophies are progressive, inherited, bilateral diseases, usually of a 
discrete layer of the cornea.   There are a variety of dystrophies that affect the anterior 
layers of the cornea including Bowman’s layer and the anterior stroma (such as 
honeycomb dystrophy, superficial granular dystrophy, and Reis-Bücklers’ dystrophy).  
These diseases are candidates for surgical treatment with penetrating keratoplasty or 
anterior lamellar keratoplasty for recurring cases after other surgical modalities (e.g., 
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superficial keratectomy) have failed.  
 Stromal dystrophies such as the three types of lattice dystrophy, macular corneal 
dystrophy, and congenital hereditary stromal dystrophy may be candidates for penetrating 
keratoplasty or deep anterior lamellar keratoplasty (DALK) (30). Phototherapeutic 
keratectomy (PTK) with excimer laser is also an option for anterior and stromal 
dystrophies, although patients may later need DALK or penetrating keratoplasty. 
 
Regraft 
 Regrafts may be necessary for any failed keratoplasty.  Graft failure may occur if 
the corneal edema fails to resolve following surgery.  This may be due to an inadequate 
endothelial cell concentration of the donor tissue or damage to the tissue from 
manipulation during surgery. 
 Graft rejection is the most common cause for graft failure and occurs in 
approximately 20% of corneal transplants (31).  Rejection of the donor cornea may occur 
at three levels: epithelial, subepithelial, or endothelial, the last of which is the most 
severe.  In general, anterior lamellar keratoplasties in which the endothelium is not 
replaced are more successful, inducing less host reaction.  Endothelial keratoplasties have 
similar rates of rejection as penetrating keratoplasty (32). 
  
History of corneal transplantation 
  
Corneal transplantation has been performed since the 19th century (32).  Since that 
time, improvements in antiseptic technique, instruments, operating microscopes, suture 
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material, and tissue banking protocols have made the procedure the most frequently 
performed organ transplant in modern times.  Currently, approximately 40,000 corneal 
transplants are performed each year in the United States (33).  Visual outcomes of 
keratoplasty have improved as surgical techniques and post-operative management have 
evolved.  For example, as the role of the endothelium was elucidated, more care was 
taken to preserve those cells during surgical manipulations.  Knowledge of limbal stem 
cells resulted in advances in treating patients with alkali burns of the cornea and limbal 
stem cell transfer.  Improvements in tissue preservation and tissue banking procedures 
increased the availability of high-quality tissue for transplantation.  Advances in 
immunomodulatory therapies decreased the incidence of graft rejection.  With each 
advance in knowledge, technology, and technique came further challenges and 
opportunities for improvement. 
 Although partial thickness transplantation of the cornea, or lamellar keratoplasty, 
has been performed as far back as 1886, it was not until the past decade that this 
technique has gained popularity as a treatment for diseases restricted to either the anterior 
cornea or the endothelium.  This situation can be attributed in part to the success of full-
thickness transplantation of the cornea, or penetrating keratoplasty (PK or PKP), 
throughout the latter half of the 20th century.  
PK has been the gold standard keratoplasty technique for many years but bears 
with it some significant limitations.  When the full thickness of the cornea is replaced 
with a donor cornea, the replacement corneal button changes the refraction of the eye and 
induces astigmatism, due to differences in curvature between the native and donor 
corneas as well as the manipulation and suturing of the graft into place.   This induced 
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refractive error and astigmatism is managed either through the use of spectacles or 
contact lenses or through a variety of surgical techniques to reduce the astigmatism (e.g., 
relaxing incisions, suture adjustment or removal, wedge resections, photorefractive 
keratectomy, laser in situ keratomilieusis or LASIK).  It can take up to several years for 
the post-operative refraction to stabilize in a transplanted eye (34). 
PK inherently reduces the structural integrity of the globe, increasing the risk of 
globe rupture with traumatic injury.  In 2004, Elder and Stack reported on a case-control 
study comparing the rates of globe rupture for 139 patients who underwent penetrating 
keratoplasty with the rates for patients undergoing cataract extraction.  They found a 
5.8% incidence of globe rupture following PK versus 0.45% for extracapsular cataract 
extraction and 0% for phacoemulsification.  The highest risk of rupture was found to be 
in the first month following surgery; however, the structural integrity of the eye following 
PK never returns to normal, and patients are always at increased risk of globe rupture 
(35).   
Penetrating keratoplasty also results in absent corneal sensation due to lack of 
innervation of the graft tissue, increasing the risk of post-operative complications and 
graft failure.  The presence of corneal sutures can exacerbate this issue, providing a nidus 
for infection or causing eye-rubbing.  In one study of 1819 eyes undergoing PK, although 
27% of failures were due to graft rejection, another 25% of failures were due to ocular 
surface disease (36).  In recent years these limitations have given rise to novel methods of 
transplanting either the anterior cornea (deep anterior lamellar keratoplasty, DALK) or 
the endothelium with varying amounts of attached stroma (endothelial keratoplasty), 
depending on the specific disease process.  It is thus possible to avoid or reduce some of 
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the major limitations of penetrating keratoplasty.   
DALK has gained favor in recent years and may be a treatment option for patients 
with corneal disease that does not affect the posterior stroma or endothelium. Clearly, the 
risk of graft rejection is lessened in DALK when compared with either PK or selective 
endothelial keratoplasty, as patients retain their native endothelium (18).  It may be an 
appropriate treatment for patients with early-stage keratoconus instead of penetrating 
keratoplasty (37).  Similar visual outcomes have been observed using DALK and 
penetrating keratoplasty for the treatment of lattice dystrophy and macular corneal 
dystrophy, although endothelial cell counts declined more in patients with macular 
corneal dystrophy who underwent DALK (38).  DALK remains a technically challenging 
surgery, but progress has been made to increase its success.  In 2002, Anwar and 
Teichmann proposed a method for separate the anterior cornea from Descemet’s 
membrane using a “big-bubble technique,” in which air is injected deep into the central 
cornea (39).  This creates a bubble between stroma and Descemet’s membrane that can 
then be used to facilitate the excision of the remaining stroma.  However, there remains a 
danger of perforating Descemet’s membrane while using the big-bubble technique.  A 
recent study reported that 23% of attempted DALK procedures had to be converted to 
penetrating keratoplasty due to this complication (40). 
 Endothelial keratoplasty, on the other hand, specifically aims to remove a 
diseased endothelium from the patient’s eye and replace it with a healthy and functional 
donor endothelium.  This method has clear advantages over full-thickness corneal 
grafting.  In its current form, endothelial keratoplasty is performed through a small (5 
mm) clear corneal incision, which reduces the surgery’s impact on the structural integrity 
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of the cornea.  Likewise, post-operative astigmatism and refractive errors are minimal 
using this technique, since the patient’s own stroma and epithelium are preserved and 
only a small amount of donor stroma is introduced.  Lastly, visual recovery is faster with 
a smaller incision.  Post-operative complications, such as those related to long-term 
suture placement and lack of corneal sensation, are also significantly reduced (32).  
José Barraquer first attempted a method for endothelial keratoplasty in the 1960s, 
but technical challenges in transplanting only a portion of the cornea limited its use vis-à-
vis penetrating keratoplasty.  Refinements in technique were necessary to make it a 
realistic alternative to PK.  Those advances began in the late 1990s when Gerrit Melles 
reported on his technique for posterior lamellar keratoplasty (PLK) (later renamed deep 
lamellar endothelial keratoplasty or DLEK), which replaced the endothelium in a 
sutureless procedure (41).  In these initial innovations, the patient’s native endothelium 
and stroma had to be painstakingly dissected out prior to replacement with the donor 
stroma and endothelium, all through a 9 mm incision.  Over the next four years, Melles 
refined his technique first through use of an air bubble in the anterior chamber to aid 
visualization (42) and later by folding the donor tissue in half and inserting it through a 5 
mm incision (43), thus reducing post-operative astigmatism and refractive errors (44).   
The next major innovation came in 2004 when Melles reported that it was not 
necessary to dissect out the patient’s native stroma and endothelium (45).  Rather, he 
showed that a descemetorhexis procedure could be used to score and strip the 
dysfunctional endothelium and Descemet’s membrane from the recipient’s eye.  This new 
technique was termed Descemet’s stripping with endothelial keratoplasty (DSEK).  The 
use of a microkeratome to automate the harvesting of the graft tissue became known as 
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Descemet’s stripping automated endothelial keratoplasty (DSAEK) and was first 
reported by Gorovoy in 2006 (44, 46).   
 
Current state of endothelial keratoplasty 
 
DSEK/DSAEK has now been widely adopted as the preferred method for 
selective transplantation of the corneal endothelium.  DSAEK has its own limitations, 
however, despite the advances that have been made and the availability of pre-cut donor 
tissue from eye banks.  Endothelial keratoplasty in general requires more tissue 
manipulation (resulting in endothelial cell death) than does penetrating keratoplasty.  
Techniques for inserting the donor tissue into the anterior chamber of the recipient eye 
involve either pushing the graft through a scleral tunnel with forceps or pulling it with 
either forceps or by a suture attached to one edge, both of which have the potential to 
damage endothelial cells (44).  More recently, efforts have been made to insert the 
DSAEK graft with injectors.   
The donor graft in DSAEK is approximately 150 microns in thickness, 
representing about 10 microns of endothelium and Descemet’s membrane attached to 140 
microns of stroma.  While the presence of the stroma does not seem to induce post-
operative astigmatism or refractive changes, nevertheless it can limit visual outcomes.  
The main difficulty has been the accumulation of fluid at the interface between the host 
and donor stroma leading to haziness and, if allowed to progress, dislocation of the graft.  
Price et al. reported a donor tissue dislocation rate of 14% in a series of his first 200 
DSEK cases (47).  Methods have been proposed to drain the interface fluid when it 
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occurs, either by massaging the eye and introducing a series of mid-peripheral corneal 
incisions to drain the fluid, as Price proposed, or by draining it with a syringe at the slit-
lamp (48).   
Other refinements have been made to the DSEK technique to address high rates of 
graft dislocation.  Terry et al. used electron microscopy to analyze graft failures in 
DSEK.  They found that roughening the recipient stromal surface was important in 
promoting adherence of the graft, through a “Velcro-like” effect between the two stromal 
surfaces (49).   
In 2002, Melles et al. described the next frontier for selectively transplanting only 
the Descemet’s membrane and endothelial cell layer, a graft only 10 microns in 
thickness, which he termed Descemet’s membrane endothelial keratoplasty (DMEK) (50, 
51).  In DMEK, the Descemet’s membrane-endothelial graft is harvested from the donor 
corneo-scleral button, leaving behind all of the donor stroma.  The resulting membrane 
spontaneously scrolls up with the endothelium on the outside.  This cigar-shaped graft 
can then be injected into the anterior chamber through a clear corneal incision, carefully 
unscrolled in the anterior chamber, and positioned on the prepared surface of the host 
stroma.  Though technically challenging, this procedure addresses some of the 
disadvantages of DSEK/DSAEK, the primary being the potential for superior visual 
outcomes and fewer graft dislocations.  Ham et al. have reported the results of 50 
consecutive cases of DMEK for Fuchs’ endothelial dystrophy, showing visual acuity of 
20/25 or better within 6 months for 75% of patients who underwent successful DMEK 
(52).  Price et al. have reported similarly encouraging results in a prospective series of 60 
(53).  An additional benefit is that DMEK eliminates the need for expensive equipment 
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for the dissection of the donor tissue, such as the femtosecond laser or microkeratome.  In 
DMEK, the surgeon harvests the membrane immediately prior to transplant using simple 
surgical instruments.  Alternatively, the Descemet’s membrane-endothelial graft may be 
harvested by a highly trained technician and preserved for later transplant.  Ham et al. 
demonstrated that this may be done with minimal decline in endothelial cell density (54). 
Alternatives to corneal transplantation exist currently in the form of an artificial 
cornea or keratoprosthesis.   This approach may be taken after multiple failed 
keratoplasties or as a temporizing measure before keratoplasty (32).  The artificial cornea 
also has the potential to provide a permanent synthetic replacement to diseased corneas.  
Similarly, there are exciting developments for the future treatment of endothelial 
dysfunction.  Endothelial cell sheets have been successfully cultured from donor corneal 
endothelium.  This raises the possibility of autologous transplantation of corneal 
endothelium that has been raised from the patient’s own cells, eliminating the risk of 
graft rejection (55).  
For the time being, DMEK appears to be the next step in corneal transplantation 
for endothelial dysfunction.  However, as previously mentioned, significant barriers 
remain to the widespread adoption of DMEK, including difficulty with reliable graft 
harvesting, problems with unscrolling the graft, and proper positioning once inserted into 
the recipient’s anterior chamber.  In a report by Ham et al. of the first 50 cases of DMEK, 
20% required a second transplant (DSEK) for graft failure (52, 54, 56).  In terms of 
difficulties with graft preparation, the Descemet’s membrane-endothelial graft is 
extraordinarily thin and prone to damage during the harvesting procedure (57).  Estimates 
and anecdotal reports of harvest failure range widely, from 5% to over 30%.  A recent 
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case series demonstrated harvest failure in 12 out of 72 attempted dissections (16.7%) 
(53).  If DMEK is to be widely adopted, reliable techniques for harvesting and 
preparation of donor tissue must be further demonstrated and refined.  Furthermore, 
factors associated with harvest outcomes must be elucidated.  This is the purpose of the 
present study.
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II. STATEMENT OF PURPOSE AND HYPOTHESIS 
 
 We describe here a case series of 40 consecutive human donor corneas that were 
dissected in order to harvest Descemet’s membrane-endothelial grafts for DMEK.  The 
primary objective of this study was to describe and refine a saline dissection technique 
for harvesting the Descemet’s membrane-endothelial graft for DMEK in a manner 
suitable for the surgical setting.  While others have used the submerged dissection 
technique (“SCUBA”) and described a “big-bubble” technique of injecting saline or air 
under Descemet’s membrane to separate it from the stroma (58), we chose the method 
described below based on our past experience examining a variety of other techniques 
(59).  
Our secondary purpose was to assess the characteristics of donor corneas for 
factors associated with successful harvesting of the membrane.  Although several case 
series of DMEK have been published (53, 57), no study has attempted to quantify those 
factors that may be associated with successful graft harvest for DMEK.  We hypothesized 
that donor tissue that had been brought to room temperature and rinsed of its preservative 
solution would be easier to dissect and result in more grafts suitable for transplantation.  
The null hypothesis is that warming and rehydrating the donor corneas would have no 
impact on harvesting the graft tissue. 
 We further hypothesized that the age of the donor tissue was an important factor 
that could be associated with successful harvest of graft tissue, with donors of younger 
age and tissue from more recently deceased donors would result in easier dissections.  
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The null hypothesis is that donor age and amount of time from death to preservation and 
from death to dissection would have no impact on successful harvest. 
 Our final purpose in undertaking this project was to gain experience in these 
novel modalities for endothelial keratoplasty and to theorize on modifications that could 
have the potential to either improve upon the visual outcomes of patients or simplify the 
surgical techniques required for these procedures.  Our resulting hybrid surgical 
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III. METHODS 
 
Donor Tissue Acquisition 
 
 A research waiver was obtained from the Yale Human Investigation Committee 
prior to beginning research.  Expired tissue suitable for transplantation was requested 
from over 50 US-based eye banks.  No compensation was offered to the eye banks for 
providing tissue.  A total of 40 corneoscleral buttons were received by and stored at the 
Yale New Haven Hospital Blood Bank prior to dissection with temperature-controlled 
refrigeration (between 2 and 8ºC).  All dissections were performed under the operating 
microscope of an ambulatory surgical center. 
 Of note, one initial human donor cornea was obtained for experimentation and 
basic refinement of technique.  Guided by our knowledge and experience with this 
cornea, we decided upon the following dissection methods to be used for rest of the graft 
harvests. 
 
Membrane Harvesting Procedure (See Figure 3) 
 
Donor tissue preparation 
Donor tissue, in the form of corneoscleral buttons, was removed from 
refrigeration at least 60 minutes prior to harvesting procedure for 32 of the 40 corneas.  
For an additional 8 trials, due to limitations of operating room scheduling and staffing, 
corneas were dissected within 30 minutes of removal from refrigeration.  Optisol GS 
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preservation medium (Chiron Ophthalmics, Irvine, California, USA) was removed and 
the donor tissue was rinsed several times with balanced salt solution (BSS) Plus (Alcon 
Laboratories, Fort Worth, Texas, USA).  The rinsing procedure involves aspiration of the 
Optisol GS medium from the graft container with a 10 or 20 cc blunt-tipped syringe.  A 
new syringe is then used to introduce enough BSS Plus to cover the graft, after which the 
saline is immediately aspirated out.  This procedure is repeated two to three more times 
with free BSS Plus each time.  After the final introduction of saline into the container, the 
graft is left to soak in the ambient temperature BSS Plus until dissection.  Attempts to 
harvest immediately after refrigeration had a statistically significant high failure rate (see 
Results section).  
 
Staining and Trephination 
Once the tissue had been soaked for the required time, it was removed from the 
BSS Plus and placed endothelial side up on a dry trephination block.  The endothelium 
was stained with trypan blue dye for one minute for improved visibility during dissection 
and, once in the recipient anterior chamber, for unscrolling of the tissue.  Once stained, 
trypan blue dye was carefully removed with Weck-Cel sponges (Medtronic ENT, 
Jacksonville, Floride, USA) and adequate staining was confirmed.   
A plastic trephination guide was placed over the tissue and an 8.5 mm disposable 
trephination blade was used to score the endothelium and Descemet’s membrane.  A 
combination of firm downward pressure, rocking, and rotation of the blade was used to 
ensure complete scoring.  Care was taken to completely score the endothelium and 
Descemet’s membrane, without scoring into or through the stroma.  
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Membrane Peeling 
Smooth-tipped forceps were used to lift the scored edge of the graft for a suitable 
dissection plane.  The edge of the scleral rim was grasped with 0.12 mm toothed forceps 
to provide counter-traction.  Areas with Descemet’s folds were avoided as they tended to 
tear easily.  Gentle manipulation of the graft edge was used to obtain a suitable dissection 
plane; too firm a grip was seen to tear the membrane.  However, the graft could still be 
salvaged even when small tears developed at the graft edge.  In this case, a new starting 
point was sought along the scored edge of the graft or gentle dissection around the area of 
the tear was used to minimize its effect. 
Once a peeling graft edge had been established, BSS Plus was applied in a 
dropwise fashion from a 25-gauge cannula to assist in peeling the leading edge of the 
graft.  The force of the falling drops seemed to minimize the tractional force needed to 
peel the graft.  If drops of BSS Plus did not adequately aid the membrane peeling (i.e., if 
the graft membrane appeared to be strongly adherent to the underlying stroma, requiring 
excessive tractional force on the membrane), hydrodissection with BSS Plus on a cannula 
was employed as an additional tool.   
Once the majority of the membrane had been peeled, the corneal well was further 
hydrated in order to facilitate the graft scrolling.  Prior to completely separating the graft 
from the stroma, it was important to lay it flat again to confirm its orientation and ensure 
that the endothelium remained on the outside of the scrolled graft.   
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Data Collection 
  
 Data were obtained from the tissue information sheets prepared by the eye bank, 
including age and sex of donor, cause of death, time and date of death, and time and date 
of tissue preservation.  Other data, such as endothelial cell count and morphology was not 
uniformly reported by the various eye banks that provided tissue for research.  Specular 
microscopy was not available to assess the endothelial cell counts before or after the 
harvesting procedure.  
 Further data was recorded at the time of each dissection trial, including the time 
and date of dissection, whether or not the tissue had been soaked in ambient temperature 
saline solution for an hour or greater, and the outcome of each peeling attempt.  
Successful peeling of the Descemet’s membrane-endothelial graft was defined as a 
procedure that produced a contiguous piece of graft tissue large enough for a typical 
transplantation (8 mm in diameter).  Small tears in the periphery of the tissue were 
deemed acceptable if the bulk of the tissue was of sufficient size and had not torn into 
separate pieces.  Small defects at the periphery of the graft would be unlikely to result in 
visually-significant stromal edema, due to their small size and their location outside of 




 All statistical analyses were implemented in Stata/SE v10.1 (StataCorp LP, 
College Station, Texas, USA).  All inferences of significance were made based on a type 
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I error rate equal to 0.05. Logistic regression analysis was employed with successful 
peeling as the dependent variable while controlling for donor age, sex, time from death to 
preservation (in minutes), time from donor death to dissection (in days), and pre-soaking 
the tissue for more than 60 minutes with ambient temperature BSS Plus as independent 
variables.  We also included the trial number as an independent variable to account for 
our own learning curve in the harvesting technique.  Stepwise backward elimination of 
variables was used to confirm the best-fit logistic regression model. 
 
 
Statement of student contribution 
 
 With the oversight and input from my advisor, I performed an initial literature 
review.  Based on the results of that review, I wrote an initial hypothesis and surgical 
harvesting procedure.  I applied for and received exemption from review from the Yale 
Human Investigations Committee (HIC) prior to obtaining human donor tissue for 
experimentation.  I solicited human donor corneas from 66 eye banks throughout the 
United States and was eventually able to secure donor tissue from six of those eye banks.  
I assisted in the arrangement for storage of the corneal tissue at the Yale-New Haven 
Hospital Blood Bank and ensured timely retrieval of the tissue on the days when we 
attempted dissection.   
 In the operating room, I assisted my advisor on all 40 attempts to harvest the 
Descemet’s membrane-endothelial graft from donor tissue, working alongside him at the 
operating microscope.  I recorded and maintained the data and results from each of these 
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sessions.  With the oversight of and input from my advisor, I decided on the statistical 
methods to be used in analysis of the acquired data, programmed the analytical code, 
performed the data analyses, interpreted the results, synthesized the conclusions, and 
prepared this written report including accompanying tables and figures. 
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IV. RESULTS 
 
Characteristics of donor tissue 
 
Forty consecutive donor corneoscleral buttons were dissected in this case series, 
using the methods described above.  The average age of donors was 61±16 years, with 
the youngest donor being 19 and the oldest 77 years of age.  Seventeen (42.5%) of the 
corneas came from female donors.  The average time from death to tissue preservation 
was 639 minutes (10.65 hours), with a range from 92 minutes to 2490 minutes (1.5 to 
41.5 hours).  The average time from donor death to corneal dissection was 19.76 days, 
with a range from 3.68 days to 47.37 days (Table 1). 
As previously mentioned, we were able to presoak 32 of the corneoscleral buttons 
in ambient temperature BSS Plus for at least one hour prior to dissection.  Due to 
limitations of operating room scheduling and staffing, the remaining 8 corneas were 
soaked in ambient temperature BSS Plus for less than a half hour prior to dissection.  
These 8 corneal dissections occurred in the second quarter of the series. 
 
Results of harvesting procedure 
 
Overall, 28 of 40 trials resulted in a tissue graft deemed suitable for 
transplantation, giving a success rate of 70.0% (Table 2).  The success rate of harvesting 
a Descemet’s membrane-endothelial graft from a cornea that had been soaked in BSS 
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Plus for more than 60 minutes was 26 of 32 (81.3%), while the success rate of harvesting 
from a cornea that been soaked in BSS Plus for less than a half hour was 2 of 8 (25.0%). 
 
Logistic regression analysis 
 
After adjusting for age, sex, time from death to preservation, and time from death 
to dissection, warming the corneas for 60 minutes to room temperature was found to be 
the only significant factor associated with successful membrane peel (adjusted odds ratio 
[OR] 17.22, 95% confidence interval [CI] 1.08-273.89, p = 0.043) (Table 3).  Age, sex, 
time from death to preservation, and time from death to dissection were not associated 
with successful graft harvest.  Furthermore, individual trial sequence number was not 
significantly associated with the success of graft harvest.  That is to say, earlier attempts 
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V. DISCUSSION 
 
Summary and implications of current research 
 
Ideally, diseases of endothelial dysfunction should be treated by selective 
replacement of the diseased endothelium with a healthy layer of new cells.  DMEK 
comes closer to this goal than any previous method of endothelial keratoplasty, using 
Descemet’s membrane as a natural carrier for an endothelial layer.  The division between 
corneal stroma and Descemet’s membrane is a natural tissue plane, which is theoretically 
less prone to the complications of interface fluid accumulation seen in DSEK.  
Furthermore, DMEK offers some significant practical advantages over DSEK.  DMEK 
may be performed using a small clear corneal incision and topical anesthesia, thus 
speeding visual recovery time and further limiting any induced refractive error and 
astigmatism.  
The success of DMEK as the next paradigm in endothelial keratoplasty relies on 
four critical steps:   
1) reliable harvesting of Descemet’s membrane-endothelial grafts;  
2) an acceptable method of insertion of the Descemet’s membrane-endothelial 
graft into the anterior chamber with minimal damage to the endothelial cell 
layer;  
3) a consistent means of unscrolling and properly positioning the graft once in the 
anterior chamber; and  
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4) satisfactory post-operative management and outcomes, including visual acuity 
and acceptable endothelial cell loss rates.   
Each of these four critical steps continues to pose challenges.  Little has been reported in 
the literature in the four years since Melles described the first case of DMEK, possibly 
due to on-going difficulties with the critical steps to successful DMEK, including the 
harvesting process, which is perhaps the most important for paving the way for future 
advances.  It is difficult to tackle the other steps without having a reliable method for 
preparing tissue grafts.  Furthermore, there have been no reports of a statistically 
validated method for reliably harvesting Descemet’s membrane for DMEK.  A variety of 
methods that have been tried and anecdotal case reports have claimed successful harvest 
of Descemet’s membrane, but without analysis of surgical or tissue factors associated 
with success (57). 
Our procedure describes a method for harvesting the Descemet’s membrane-
endothelial graft with an overall success rate of 70.0%.  By itself, a 30% failure rate for 
one step of the surgical procedure would not be acceptable.  However, we found that 
when donor tissue was soaked in BSS Plus and warmed to ambient temperature for at 
least 60 minutes, the success rate improved to 81.3%.  This was the only statistically 
significant factor that we found to be associated with successful harvesting.  We have 
previously reported that rinsing with saline is an important factor contributing to success 
in DSEK graft adherence (60).  While rinsing the preservative medium from graft tissue 
may improve graft adherence, we hypothesize that warming and soaking the donor tissue 
may serve an additional purpose in rehydrating the tissue before graft harvest.  This may 
allow for easier access to the natural tissue plane between Descemet’s membrane and the 
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stroma.  Histological studies would be needed to assess the underlying cause of this 
difference in tissue handling.   
Regardless of the histologic reason for improved graft harvest, we believe this 
result to be an important step towards making DMEK a viable option for patients with 
endothelial dysfunction.  Just as the recognition of the importance of the endothelium 
lead to surgeons taking more care with the manipulation of graft tissue for penetrating 
keratoplasty, so too might this research change the way donor tissue is prepared for 
dissection prior to DMEK. 
 
Limitations of the study 
 
There are several important limitations to this case series.  First, we were unable 
to assess the impact of our technique on endothelial cell density (ECD) due to 
inconsistent reporting from the source eye banks.  Other studies have shown acceptable 
ECDs after harvesting, with a 30% decline in ECD in the 6 months after DMEK, similar 
to other forms of endothelial keratoplasty (52), but we were unable to assess that here.   
Second, our case series includes only 40 corneal dissections, a small number 
which limits our ability to make statistical inferences about the factors associated with 
success or failure.  Nonetheless, we were able to show a statistically significant 
association of presoaking the corneas in ambient temperature BSS Plus for 60 minutes or 
more with successful graft harvest.  It remains unclear whether the soaking of the donor 
tissue with BSS Plus, the warming to ambient temperature, or the combination of the two 
was the most important factor associated with improved success in this technique. 
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Third, these 40 dissections were also our first attempts to dissect corneal tissue 
systematically for the purpose of preparing tissue for DMEK.  There is undoubtedly a 
learning curve associated with these delicate dissections.  Although we found no 
association of the attempt number with successful harvest, the learning curve nevertheless 
may have influenced our success with harvesting the Descemet’s membrane-endothelial 
graft.  We would expect the success rate to improve with more practice.  Of note, the 
factor that was found to be significantly associated with harvest failure in this series (i.e., 
not warming and presoaking the tissue) occurred exclusively in the second quarter of the 
series, from harvest sequence number 11 to 18.   This may have been a confounding 
factor of our findings.  With more experience and a larger case series, the effects of the 
experiential learning curve on the study would be diminished, perhaps allowing for other 
true associations to emerge.  
Lastly, although we attempted to adjust for as many factors as possible, there may 
have been other unmeasured factors that influenced our success or failure with graft 
harvest.  In addition, we were not blinded to the characteristics of the donor corneal tissue 
that we dissected; this may have influenced our successful harvesting of the graft 
membrane. 
 
Future directions: Hybrid DSEK/DMEK techniques and InjEK 
 
We believe that this research is an important step towards the reliable harvesting 
of Descemet’s membrane-endothelial grafts for DMEK.  However, the remaining 
technical challenges involved in DMEK may make it too daunting a procedure for 
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widespread adoption by corneal surgeons.  Until those challenges are satisfactorily 
addressed, other methods for selective endothelial cell transfer should be considered.   
Specifically, it may be advantageous to keep a small amount of adherent stroma 
(but not as much as in DSEK) with the endothelial graft in order to facilitate surgical 
manipulation.  One such DSEK/DMEK “hybrid” technique has already been described by 
McCauley et al., who, keeping to tradition, call it Descemet’s membrane automated 
endothelial keratoplasty or DMAEK (58).  Studeny et al. have described a similar 
technique that they call Descemet’s membrane endothelial keratoplasty with stromal ring 
or DMEK-S (61).  In the first procedure, a microkeratome is used to remove the anterior 
cornea.  Then, a big-bubble technique (as in DALK) is used to detach the central stroma 
from Descemet’s membrane.  The central stroma is excised but a rim of stroma is left 
attached to the bare Descemet’s membrane.  The residual stromal rim allows the tissue to 
be folded and inserted as in DSAEK, and provides enough elastic rebound to 
spontaneously unfold once inside the anterior chamber.  In Studeny’s method, no 
microkeratome is used and the tissue is dissected manually using the big-bubble 
technique.  They also leave a rim of stroma attached to the bare Descemet’s membrane.  
Potentially, these techniques may combine the visual outcomes of DMEK with the ease 
of tissue manipulation found in DSAEK.   Unfortunately, both of these procedures 
remain technically challenging.  Chiefly, the use of the big-bubble technique may cause 
breaks or tears in Descemet’s membrane, making the tissue unusable.  
We also propose a hybrid technique between DSAEK and DMEK, which aims to 
combine the benefits of DSAEK (graft stability, ease of surgical manipulation) with some 
of the advantages of DMEK (small clear corneal incision, topical anesthesia, fast 
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recovery time).  This technique uses an off-label intraocular lens injector system for 
inserting a precut endothelial graft into the anterior chamber.  However, in this method 
we use a precut graft that is much thinner than in typical DSAEK.  Whereas in DSAEK, 
the graft is approximately 150 microns thick, in this procedure the graft may be 50-75% 
thinner (40-70 microns).  The thinness of the graft makes it possible for the tissue to be 
gently placed in the IOL injector and inserted instead of folded, grasped with forceps, and 
pushed through a scleral tunnel as in DSAEK.  We have nicknamed it “InjEK” for 
Injector-assisted endothelial keratoplasty (See Figure 4). 
As mentioned above, the benefits of this procedure are the better graft stability of 
DSAEK and the improved recovery time of DMEK.  The major drawback of this 
approach is that it preserves DSAEK’s limitations in terms of fluid accumulation at the 
stromal interface, potentially leading to limited visual outcomes or graft detachment.   
The most important advantage that this technique offers over all other forms of 
endothelial keratoplasty is the simplification of surgical technique.  In contrast to 
DSAEK (which is often done via a scleral tunnel, leading to a longer recovery time) and 
DMEK (which requires extraordinarily delicate tissue dissection in all of its iterations), 
this procedure would require no more training than that which is needed for a basic 
cataract extraction and have a short recovery time. 
In time, with the aide of the present study, we expect that the barriers that 
currently exist to widespread adoption of DMEK will be overcome.  In the meantime, 
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VII. FIGURES 
 
Figure 1: Corneal microarchitecture in cross section, from Robbins Pathology 7th ed.   
 
Legend: The inset at top left reveals (e) the epithelial layer of stratified squamous 
epithelium, (b) Bowman’s layer (anterior elastic lamina) of condensed collagen fibers, 
and (s) the stroma (substantia propria) consisting of approximately 200 layers of collagen 
fibers with sparse keratocytes.  The inset at bottom right reveals the dark layer of 
basement membrane called Descemet’s membrane, and the monolayer of endothelial 
cells between Descemet’s membrane and the aqueous humor of the anterior chamber. 
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Figure 2: Fuchs’ Endothelial Dystrophy on slit-lamp examination, from Yanoff & Duker 
Ophthalmology, 3rd ed.  Note guttae in the slit-lamp beam. 
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Figure 3: Descemet’s membrane harvesting procedure, as described in the text.   
 
 
Legend: From left to right: a) Corneoscleral button mounted on trephination block and 
stained with trypan blue dye.  b) Tissue with scoring guide.  c) Scoring tissue with 8.5 
mm trephine with twisting motion, while holding tissue steady with forceps.  d) Finding 
an edge for peeling.  e) Adherent edge of graft.  f) BSS Plus in dropwise fashion to assist 
in initiating peel. Note the 180° rotation of the cornea (from image 4 to 6) that was 
performed in search of a suitable dissection edge.  g) Continued peel with drops of BSS 
Plus.  h) Progressive peeling with BSS Plus.  i) Successful scroll of Descemet’s 
membrane. 
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Figure 4: Injector-assisted Endothelial Keratoplasty (InjEK), as described in the text.   
 
 
Legend: From left to right: a) Descemetorhexis of recipient eye. b) Removal of DM from 
recipient eye.  c) Stromal roughening. d) Trephination of thin-cut donor membrane.  e) 
Loading of graft into IOL injector. f) Advancing graft to tip of injector. g) Loading BSS 
and viscoelastic behind graft. h) Graft loaded in tip of injector. i) Insertion of graft 
through clear corneal incision. j) Injection of air bubble. k) Centering of graft. l) Final 
result.
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VIII. TABLES 



















1 4:26 18.70 62 F Yes Yes 
2 6:10 15.03 77 F Yes Yes 
3 5:24 17.88 49 M Yes Yes 
4 6:10 15.03 77 F Yes No 
5 3:08 21.89 45 M Yes Yes 
6 6:11 20.82 77 F Yes No 
7 3:08 21.89 45 M Yes Yes 
8 3:25 18.49 76 M Yes Yes 
9 6:11 20.82 77 F Yes Yes 
10 3:25 18.49 76 M Yes Yes 
11 11:17 18.64 72 F No Yes 
12 11:17 18.64 72 F No No 
13 11:31 16.21 32 F No Yes 
14 21:18 20.94 19 M No No 
15 21:18 20.94 19 M No No 
16 11:31 16.21 32 F No No 
17 9:27 4.83 57 F No No 
18 9:27 4.83 57 F No No 
19 12:39 13.43 74 F Yes Yes 
20 12:39 13.43 74 F Yes Yes 


















21 1:32 12.54 74 M Yes Yes 
22 1:32 12.54 74 M Yes Yes 
23 24:25 12.00 73 F Yes Yes 
24 24:25 12.00 73 F Yes Yes 
25 21:53 13.55 51 M Yes Yes 
26 21:53 13.55 51 M Yes Yes 
27 3:35 3.68 69 F Yes Yes 
28 3:35 22.60 69 F Yes Yes 
29 5:43 29.46 52 M Yes No 
30 5:43 29.46 52 M Yes Yes 
31 10:19 47.37 71 M Yes Yes 
32 3:54 24.04 61 M Yes Yes 
33 10:19 47.37 71 M Yes Yes 
34 3:54 24.04 61 M Yes No 
35 41:30 22.52 59 M Yes No 
36 8:23 19.22 73 M Yes No 
37 8:23 19.22 73 M Yes Yes 
38 41:30 22.52 59 M Yes Yes 
39 5:18 32.76 57 M Yes Yes 
40 5:18 32.76 57 M Yes Yes 
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Table 2: Success rates for Descemet’s membrane-endothelium harvest 
 Success Percent 
Overall 28/40 70.0% 
Warmed 26/32 81.3% 




Table 3: Logistic regression analysis of 40 trials of Descemet’s membrane-endothelium 
harvest 
 OR 95% CI p-value 
Warmed 17.62 1.10-283.25 0.043 * 
Age 1.00 0.93-1.07 0.904 
Female 1.53 0.14-16.55 0.726 
Time (Death to Preservation) 0.67 0.09-4.95 0.692 
Time (Death to Dissection) 1.01 0.91-1.12 0.823 
Trial number 0.98 0.90-1.08 0.738 
* statistically significant 
 
 
 
 
